Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation

References

• Myers J, Mires G, Macleod M, Baker P. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 2005; 45: 258–263
   PubMed Web of Science ®Google Scholar
• Madazali R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797–802
   PubMed Web of Science ®Google Scholar
• Redman C W, Sacks G P, Sargent I L. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506
   PubMed Web of Science ®Google Scholar
• Velzing-Aarts F V, Muskiet F A, van der Dijs F P, Duits A. High serum interleukin-8 levels in Afro-Caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, Duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002; 48: 319–322
   PubMed Web of Science ®Google Scholar
• Mellembakken J R, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 2001; 38: 394–398
   PubMed Web of Science ®Google Scholar
• Halim A, Kanayama N, Maradny E, Maehara K, Takahashi A, Nosaka K, Fukuo S, Amamiya A, Kobayashi T, Terao T. Immunohistological study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy. Gynecol Obstet Invest 1996; 41: 106–112
   PubMed Web of Science ®Google Scholar
• Kauma S, Takacs P, Scordalakes C, Walsh S, Green K, Peng T. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002; 100: 706–714
   PubMed Web of Science ®Google Scholar
• Leonard E J. NAP-1 (IL-8). Immunol Today 1990; 11: 223–224
   PubMedGoogle Scholar
• Smith W B, Gamble J R, Clark-Lewis I, Vadas M A. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991; 72: 65–72
   PubMed Web of Science ®Google Scholar
• Puchner T, Egarter C, Wimmer C, Lederhilger F, Weichselbraun I. Amniotic fluid interleukin-8 as a marker for intraamniotic infection. Arch Gynecol Obstet 1993; 253: 9–14
   PubMed Web of Science ®Google Scholar
• Tilg H, Ceska M, Vogel W, Herold M, Margreiter R, Huber C. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992; 53: 800–803
   PubMed Web of Science ®Google Scholar
• Sticherling M, Bornscheuer E, Schröder J M, Christophers E. Localization of neutrophil-activating peptide-1/interleukin-8 immunoreactivity in normal and psoriatic skin. J Invest Dermatol 1991; 96: 26–30
   PubMed Web of Science ®Google Scholar
• Gimbrone M A, Obin M S, Brock A F, Luis E A, Haas P E, Hebert C A, Yip Y K, Leung D W, Lowe D G, Kohr W J, et al. Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246: 1601–1603
   PubMed Web of Science ®Google Scholar
• Wang X, Athayde N, Trudinger B. Fetal plasma stimulates endothelial cell production of cytokines and the family of suppressor of cytokine signaling in umbilical placental vascular disease. Am J Obstet Gynecol 2003; 188: 510–516
   PubMed Web of Science ®Google Scholar
• Kayisli U A, Mahutte N G, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002; 47: 213–221
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu Y, Zhang Y, Lewis D F. Evidence of endothelial dysfunction in preeclampsia: Decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004; 190: 817–824
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gu Y, Li H, Lucas M J, Wang Y. Increased endothelial monolayer permeability is induced by serum from women with preeclampsia but not by serum from women with normal pregnancy or that are not pregnant. Hypertens Pregnancy 2003; 22: 99–108
   PubMed Web of Science ®Google Scholar
• Johnson M R, Anim-Nyame N, Johnson P, Sooranna S R, Steer P J. Does endothelial cell activation occur with intrauterine growth restriction?. BJOG 2002; 109: 836–839
   PubMed Web of Science ®Google Scholar
• Greer I A, Lyall F, Perera T, Boswell F, Macara L M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction?. Obstet Gynecol 1994; 84: 937–940
   PubMed Web of Science ®Google Scholar
• Buemi M, Marino D, Floccari F, Ruello A, Nostro L, Aloisi C, Marino M T, Di Pasquale G, Corica F, Frisina N. Effect of interleukin-8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension. Curr Med Res Opin 2004; 20: 19–24
   PubMed Web of Science ®Google Scholar
• Wang X, Baier J, Adair C D, Lewis D F, Krueger S, Kruger T, Gurski M, Brown E. Interleukin-8 stimulates placental prostacyclin production in preeclampsia. Am J Reprod Immunol 1999; 42: 375–380
   PubMed Web of Science ®Google Scholar
• Bretelle F, Sabatier F, Shojai R, Agostini A, Dignat-George F, Blanc B, d'Ercole C. [New insight in physiopathology of preeclampsia and intra-uterine growth retardation: Role of inflammation] [Article in French]. Gynecol Obstet Fertil 2004; 32: 482–489
   PubMedGoogle Scholar
• Abdollahi T, Robertson N M, Abdollahi A, Litwack G. Identification of interleukin-8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in ovarian carcinoma cell line OVCAR3. Cancer Res 2003; 63: 4521–4526
   PubMed Web of Science ®Google Scholar